NDLI: Intrapulmonary Concentrations of Pyrazinamide

Content Provider	PubMed Central
Author	Conte, John E. Golden, Jeffrey A. Duncan, Sheila Mckenna, Elaine Zurlinden, Elisabeth
Copyright Year	1999
Abstract	The objective of this study was to compare the steady-state plasma and intrapulmonary concentrations of orally administered pyrazinamide in normal volunteers and subjects with AIDS. Pyrazinamide was administered at 1 g once daily for 5 days to 40 adult volunteers (10 men with AIDS, 10 normal men, 10 women with AIDS, and 10 normal women). Subjects with AIDS and with more than four stools per day were excluded. Blood was obtained prior to administration of the first dose, 2 h after the last dose, and at the completion of bronchoscopy and bronchoalveolar lavage, which were performed 4 h after the last dose. Standardized bronchoscopy was performed without systemic sedation. The volume of epithelial lining fluid (ELF) recovered was calculated by the urea dilution method. The total number of alveolar cells (AC) was counted in a hemocytometer, and differential cell counting was performed after cytocentrifugation. Pyrazinamide was measured by high-performance liquid chromatography. The presence of AIDS or gender had no significant effect on the concentrations of pyrazinamide in plasma. The concentrations of pyrazinamide in ELF and AC were lower in the subjects with AIDS than in the subjects without AIDS, but the difference was not significant. The concentrations in plasma (mean ± standard deviation) were 25.1 ± 7.6 and 21.1 ± 6.8 μg/ml at 2 and 4 h after the last dose, respectively, and were not significantly different from the concentration (17.4 ± 16.9 μg/ml) in AC. The concentration of pyrazinamide in ELF was high (431 ± 220 μg/ml) and was approximately 4 to 40 times the reported MIC for pyrazinamide-susceptible strains of Mycobacterium tuberculosis. The high concentration of pyrazinamide in ELF may contribute in part to the effectiveness of the drug in treating pulmonary tuberculosis.
Starting Page	1329
File Format	PDF
ISSN	10986596
e-ISSN	10986596
Journal	Antimicrobial Agents and Chemotherapy
Issue Number	6
Volume Number	43
Language	English
Publisher	American Society for Microbiology
Publisher Date	1999-06-01
Access Restriction	Open
Rights Holder	American Society for Microbiology
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases Pharmacology Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid

Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.

Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid

Effects of AIDS and Gender on Steady-State Plasma and Intrapulmonary Ethionamide Concentrations

Effects of AIDS and Gender on Steady-State Plasma and Intrapulmonary Ethambutol Concentrations

Intrapulmonary Pharmacokinetics of Linezolid

Intrapulmonary Pharmacokinetics of GSK2251052 in Healthy Volunteers

A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide

Intrapulmonary Concentrations of Pyrazinamide

Similar Documents

Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid

Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.

Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid

Effects of AIDS and Gender on Steady-State Plasma and Intrapulmonary Ethionamide Concentrations

Effects of AIDS and Gender on Steady-State Plasma and Intrapulmonary Ethambutol Concentrations

Intrapulmonary Pharmacokinetics of Linezolid

Intrapulmonary Pharmacokinetics of GSK2251052 in Healthy Volunteers

A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide

Intrapulmonary Concentrations of Pyrazinamide